Authors: THEIS JGW CHAN HSL GREENBERG ML MALKIN D KARASKOV V MONCICA I KOREN G DOYLE J

Citation: Jgw. Theis et al., INCREASED SYSTEMIC TOXICITY OF SARCOMA CHEMOTHERAPY DUE TO COMBINATION WITH THE P-GLYCOPROTEIN INHIBITOR CYCLOSPORINE, International journal of clinical pharmacology and therapeutics, 36(2), 1998, pp. 61-64

Authors: THEIS JGW CHAN HSL GREENBERG ML MALKIN D KARASKOV V MONCICA I KOREN G DOYLE J

Citation: Jgw. Theis et al., TOXICITY ASSESSMENT IN CHILDREN RECEIVING CANCER-CHEMOTHERAPY WITH CYCLOSPORINE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 31-31

Authors: BLOWEY DL MONCICA I SCOLNIK D ARBUS GS HEBERT D BALFE JW KOREN G

Citation: Dl. Blowey et al., THE PHARMACOKINETICS OF EXTENDED-RELEASE FELODIPINE IN CHILDREN, European Journal of Clinical Pharmacology, 50(1-2), 1996, pp. 147-148

Authors: BLOWEY DL MONCICA I OH PI SCOLNIK D ARBUS GS HEBERT D BALFE JW KOREN G

Citation: Dl. Blowey et al., FELODIPINE COMPLIANCE, BLOOD-PRESSURE (BP) CONTROL AND PHARMACOKINETICS (PK) IN HYPERTENSIVE CHILDREN, Pediatric research, 37(4), 1995, pp. 359-359

Authors: MONCICA I OH PI QAMAR IU SCOLNIK D ARBUS GS HEBERT D BALFE JW KOREN G

Citation: I. Moncica et al., A CROSSOVER COMPARISON OF EXTENDED-RELEASE FELODIPINE WITH PROLONGED ACTION NIFEDIPINE IN HYPERTENSION, Archives of Disease in Childhood, 73(2), 1995, pp. 154-156